Background: Vitamin D fortification of noncow's milk beverages is voluntary in North America. The effect of consuming non-cow's milk beverages on serum 25-hydroxyvitamin D levels in children is unclear. We studied the association between non-cow's milk consumption and 25-hydroxyvitamin D levels in healthy preschool-aged children. We also explored whether cow's milk consumption modified this association and analyzed the association between daily non-cow's milk and cow's milk consumption.
G
oat's milk and plant-based milk alternatives made from soy, rice, almonds, coconut, hemp, flax or oats (herein called "non-cow's milk") are increasingly available on supermarket shelves. Many consumers may be switching from cow's milk to these beverages. [1] [2] [3] Parents may choose non-cow's milk beverages for their children because of perceived health benefits. However, it is unclear whether they offer health advantages over cow's milk or, alternatively, whether they increase the risk of nutritional inadequacy.
In the United States and Canada, cow's milk products are required to contain about 40 IU of vitamin D per 100 mL, making it the major dietary source of vitamin D for children. [4] [5] [6] [7] [8] The only other food source with mandatory vitamin D fortification in Canada is margarine, which is required to contain 53 IU per 10 mL (10 g). 5 Fortification of non-cow's milk beverages with vitamin D is also possible, but it is voluntary in both countries. Furthermore, there is little regulation on the vitamin D content even if such beverages are fortified. 5, 6, 9 We conducted a study to test the association between total daily consumption of non-cow's milk and serum 25-hydroxyvitamin D levels in a population of healthy urban preschool-aged children attending routinely scheduled well-child visits. We hypothesized that vitamin D stores would be lower in children who consume non-cow's milk. The secondary objectives were to explore how consumption of cow's milk might modify this association and to study the association between daily intake of non-cow's milk and cow's milk.
Children 1-6 years of age were recruited from 7 pediatric or family medicine primary care practices during routinely scheduled well-child visits between December 2008 and September 2013. We excluded children who had a condition affecting growth (e.g., failure to thrive, cystic fibrosis), a chronic illness (excluding asthma) or severe developmental delay.
Data collection
Data were collected from parents by a trained research assistant at each participating practice using a standardized data-collection form adapted from the Canadian Community Health Survey. 11 The research assistants also obtained physical measurements of the children. Venous blood sampling was performed by a trained phleb otomist, and daily samples were sent to the Clinical Biochemistry Laboratory at Mount Sinai Hospital in Toronto.
The total serum 25-hydroxyvitamin D level, the primary outcome measure, was determined with the use of a 2-step competitive chemiluminescence assay (LIAISON 25 OH Vitamin D TOTAL Assay; DiaSorin). This machine has been extensively tested and validated to show an intra-assay imprecision of 7.2% at a concentration of 213 nmol/L, and an interassay imprecision of 4.9% at 32 nmol/L, 8.9% at 77 nmol/L and 17.4% at 213 nmol/L, values that are well within acceptable limits for biochemical measurements. 12, 13 Our primary exposure variable was the total consumption of non-cow's milk per day. The amount was determined from the response to the following standardized question on the datacollection form: "How many 250-mL cups of non-cow's milk (soy, rice, goat, etc.) does your child have currently in a typical day?"
The research assistants collected data on the following prespecified covariates hypothesized to influence the association between total consumption of non-cow's milk and 25-hydroxyvitamin D levels: age, sex, body mass index (BMI) z score, daily vitamin D supplementation, consumption of cow's milk, consumption of margarine, skin pigmentation, outdoor play time and date of laboratory testing. Weight was measured with a baby scale for children under the age of 2 years and a precision digital scale (Seca model 703, measurement accuracy ± 0.025%; Seca) for older children. The length of children under the age of 2 was measured with a calibrated length board; the height of older children was measured with a calibrated stadiometer (Seca). BMI was calculated using the standard formula (weight/height 2 , where weight is measured in kilograms, and height is measured in metres). 14, 15 The BMI z score was calculated with the use of the World Health Organization growth curves. 16 These curves are recommended for use in this age group in Canada because they reflect optimal growth in children. 17, 18 Daily vitamin D supplementation was determined from the data-collection form as the daily use of a vitamin D supplement or multivitamin; all children's over-the-counter multivitamins in Canada contain a dose of 400 IU. 19 The amount of cow's milk consumed daily was determined from the response to the following question on the form: "How many 250-mL cups of cow's milk does your child have currently in a typical day?" Margarine consumption (Yes or No) was determined according to whether the child ate margarine in the 3 days before the well-child visit. The research assistants used the Fitzpatrick scale, a skin pigmentation classification system used commonly in dermatologic research, to measure skin pigmentation. 20 Outdoor playtime was the number of hours per week spent outside playing, as reported on the form.
Statistical analysis
Descriptive statistics were performed for the primary exposure and outcome variables and the covariates with the use of t tests for continuous variables and χ 2 tests for categorical variables. A univariable linear regression model was used to determine the unadjusted association between the primary exposure (total consumption of noncow's milk) and the primary outcome (serum 25-hydroxyvitamin D level).
For our primary analysis, we developed a multiple linear regression model to test the association between total consumption of non-cow's milk and 25-hydroxyvitamin D levels, adjusted for prespecified and clinically relevant covariates (listed in the preceding section). To account for the seasonal effect on 25-hydroxyvitamin D levels, a sinusoidal function was applied to the date of laboratory testing. All covariates were included in the final model regardless of statistical significance to avoid biased regression coefficients and standard errors and to avoid artificially inflated R 2 values. 21 To explore whether consumption of cow's milk modified the association between the primary exposure and out-come, we tested the interaction between total consumption of non-cow's milk and any cow's milk consumption at a significance level of α = 0.05. We also explored the risk of having a low 25-hydroxyvitamin D level (< 50 nmol/L) using an adjusted logistic regression model. 22, 23 For our secondary analysis, we developed a multiple linear regression model to explore the association between non-cow's milk consumption and cow's milk consumption (measured in 250-mL cups per day), adjusted for age and sex. To ensure the variables in the models produced independent effects, we assessed multicolinearity for all covariates using the variance inflation factor. This factor is a measure of the degree of inflation in the standard errors of regression coefficients when multicolinearity exists (i.e., variance inflation factor > 5). 24, 25 All variance inflation factors were below 5.
Residual plots of serum 25-hydroxyvitamin D levels against total consumption of noncow's milk were used to assess linearity of the association between the primary exposure and the primary outcome. The outcome variable, 25-hydroxyvitamin D level, was positively skewed and was log-transformed, which resulted in a normal distribution. Model checking with the use of residual analysis on the transformed outcome indicated a good fit. No variable had more than 12% missing data. However, to overcome biases that can result from missing data, multiple imputation was performed. 21 Models were run on 50 imputed datasets, and the results of the individual analyses were combined to obtain valid statistical inferences in the final analysis. 21 Be-
(no laboratory testing)
Children with parental consent who met the inclusion criteria n = 4523
Data on milk consumption available n = 2468
No data on milk consumption (imputed for the analysis) n = 363
Included in the analysis n = 2831 cause the outcome variable, 25-hydroxyvitamin D level, had minimal missing data (6%), we did not impute missing data for it. 21 All statistical analyses were conducted with the use of SAS 9.3 for Windows and R Studio version 0.95.
Ethics approval
The study was approved by the Hospital for Sick Children and St. Michael's Hospital Research Ethics Boards. Consent was obtained from the parents of all children participating in the study.
Results
Of the 4523 children who met the inclusion criteria and for whom consent was obtained, 2831 were included in the study because they had undergone laboratory testing (Figure 1 ). Baseline characteristics of the participants and nonparticipants are shown in Results for our primary analysis using multiple linear regression are shown in Table 2 . The interaction between total consumption of non-cow's milk beverages and consumption of any cow's milk was statistically significant (p = 0.03), which suggested that drinking cow's milk was an effect modifier of the association between total noncow's milk consumption and 25-hydroxyvitamin D levels (Figure 3) . After adjusting for clinically relevant covariates, we found that each additional 250-mL cup of non-cow's milk beverage consumed by children who also drank cow's milk was associated with a 5.1% (p = 0.008) decrease in the 25-hydroxyvitamin D level and a drop in the median 25-hydroxyvitamin D level of 4.2 nmol/L (95% CI 1.1 to 7.1 nmol/L) ( Table 2) . Statistically significant covariates (p < 0.001) included vitamin D supplementation, which was associated with increased 25-hydroxyvitamin D levels, and not drinking cow's milk and having dark skin pigmentation, which were associated with decreased serum levels. These covariates did not change the parameter estimate for 25-hydroxyvitamin D by more than 15% when individually removed from the model, which suggested that they were not confounders of the association between total noncow's milk consumption and 25-hydroxyvitamin D levels.
In the logistic regression model, children who drank only non-cow's milk beverages were at higher risk of having a 25-hydroxyvitamin D level below 50 nmol/L than children who drank only cow's milk (odds ratio 2.7, 95% CI 1.6 to 4.7).
In our secondary analysis, the age-and sexadjusted multiple linear regression showed an inverse association between total daily intake of non-cow's milk beverages and cow's milk (Figure 4) . Each additional 250-mL cup of non-cow's milk consumed was associated with a 0.5-cup decrease in consumption of cow's milk in both the unadjusted and adjusted regression analyses (95% CI 0.4 to 0.6 cups in the adjusted analysis).
Interpretation
More than 10% of the children in our study drank non-cow's milk beverages on a regular basis. We identified an independent association [33] [34] [35] [36] [37] [38] [39] One strategy to increase vitamin D intake is targeted vitamin D supplementation. Alternatively, standardized, legislated vitamin D content for all milk products, including non-cow's milk beverages, could level the vitamin D gradient between children who drink cow's milk and those who drink non-cow's milk products. 40 According to the Food and Drug Regulations of Canada, the term "milk" can be used only on products obtained from a cow and fortified with vitamin D. 6 Thus, non-cow's milk products are commonly labelled as "beverages" without the inclusion of the term milk and therefore fall outside the scope of legislation for vitamin D content and monitoring.
Strengths and limitations
Strengths of our study include its relatively large sample from an ethnically diverse population of healthy young urban children with rich clinical and laboratory data, which allowed us to take into account a range of clinically important potential confounders.
Limitations of our study include its crosssectional design, from which causality cannot be determined. Parent-reported measurements of survey data may have been susceptible to recall bias.
Children included in the study had lighter skin pigmentation and higher vitamin D supplementation than the nonparticipants had; thus, our findings may not be generalizable to children from other urban areas or from nonurban areas who may be at higher risk of vitamin D deficiency. However, the median serum 25-hydroxyvitamin D level was similar to the median levels in other population-based studies of this age group.
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Conclusion
We identified a dose-dependent association between consumption of non-cow's milk beverages in early childhood and decreased serum levels of 25-hydroxyvitamin D. This association was modified by cow's milk consumption, which suggests a trade-off between the consumption of cow's milk fortified with higher levels of vitamin D and non-cow's milk beverages with lower vitamin D content. Our findings may be helpful for health care providers caring for children who drink non-cow's milk beverages because of an allergy to cow's milk, lactose intolerance or a dietary preference. Improved education regarding nutrition labels is important to ensure that non-cow's milk products fortified with vitamin D are being chosen by parents and caregivers, and improved package labelling may help parents make informed decisions about healthy beverages for their children. Standardization of vitamin D content of both cow's milk and non-cow's milk products would make decisions simpler. Future research on the type and brand of non-cow's milk products is needed to understand better the association between consumption of specific types of non-cow's milk beverages and serum 25-hydroxyvitamin D levels in childhood.
